Cytosorbents Corp Stock OTC Bulletin Board
Stocks
CTSO
US23283X1072
Advanced Medical Equipment & Technology
| Market Cap | 27.48M 23.96M 22.19M 20.77M 38.96M 2.59B 39.2M 263M 102M 1.28B 103M 101M 4.43B | P/E 2026 * |
-2.37x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 27.48M 23.96M 22.19M 20.77M 38.96M 2.59B 39.2M 263M 102M 1.28B 103M 101M 4.43B | EV / Sales 2026 * |
0.72x | EV / Sales 2027 * | 0.58x |
| Free-Float |
84.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytosorbents Corp
| 1 day | -6.91% |
| Manager | Title | Age | Since |
|---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 55 | 2008-07-23 |
Peter Mariani
DFI | Director of Finance/CFO | 62 | 2024-08-13 |
Vincent Capponi
PSD | President | 68 | 2020-04-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Jones
BRD | Director/Board Member | 77 | 2011-07-24 |
Phillip Chan
BRD | Director/Board Member | 55 | 2008-12-31 |
Alan Sobel
BRD | Director/Board Member | 65 | 2014-11-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.91% | -.--% | - | - | 27.48M | |
| +0.63% | -1.01% | +18.35% | -13.53% | 173B | |
| +1.14% | -1.04% | -20.16% | +23.51% | 144B | |
| -0.33% | -1.63% | -8.88% | -26.73% | 125B | |
| +0.76% | -3.45% | -55.32% | -16.62% | 67.32B | |
| +0.78% | +2.64% | +18.09% | -4.98% | 50.3B | |
| -0.58% | -1.16% | -25.42% | -34.65% | 44.09B | |
| +2.20% | -2.14% | +9.99% | +4.90% | 35.89B | |
| -0.44% | -0.03% | +4.74% | +32.04% | 34.9B | |
| +0.72% | -5.51% | -14.33% | -21.69% | 28.02B | |
| Average | -0.20% | -1.86% | -8.11% | -6.42% | 78.07B | |
| Weighted average by Cap. | +0.54% | -1.89% | -6.64% | -6.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.26M 33.36M 30.9M 28.92M 54.25M 3.61B 54.58M 367M 142M 1.78B 144M 141M 6.17B | 47.12M 41.09M 38.05M 35.62M 66.81M 4.45B 67.21M 451M 175M 2.19B 177M 173M 7.6B |
| Net income | -11.74M -10.24M -9.48M -8.88M -16.65M -1.11B -16.75M -112M -43.59M -545M -44.07M -43.13M -1.89B | 2.37M 2.07M 1.92M 1.79M 3.36M 224M 3.38M 22.73M 8.81M 110M 8.91M 8.72M 383M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
